Global Pharmaceutical CMO Market Analysis, 2019-2024 - Advancements in Continuous Manufacturing Technology, Necessary to Meet New Demand in the Orphan Drugs Segment

News provided by

Dec 19, 2019, 12:30 ET

DUBLIN, Dec. 19, 2019 /PRNewswire/ -- The "Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

This research service covers these technology trends with case examples of how some CMOs are ahead of the curve in adopting these technologies.

This study also covers the global market for pharmaceutical contract manufacturing for Active Pharmaceutical Ingredient (API) and Finished Dosage Form (FDF) manufacturing. It provides a comprehensive and critical analysis of subsectors, including generic APIs, novel APIs, HPAPIs, solid dosage forms, and injectable dosages. The study also examines top developed and emerging national markets, challenges in each of these markets, and hidden opportunities.

For example, in the US, where generic drug penetration is heavy at almost 80% and China, India, Russia, and Mexico where levels are as high as 90%, the CMO market has reached saturation and, therefore, CMOs can explore opportunities in lifecycle management of legacy products and redesigning synthesis routes to create high-tech generics.

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners instead of contractors. Sponsors are looking for partnerships to not only append their existing capacity and get access to new markets but also to mitigate risk and bring overhaul in manufacturing technologies. Consequently, safety, efficacy, and product quality are outweighing cost-saving considerations.

CMOs are also stepping up to the growing demand by investing in containment technology to meet HPAPI demand, introducing distributed manufacturing to take manufacturing closer to the patient, and adopting continuous manufacturing and digitization of processes. For example, CMOs are partnering with third-party vendors for layered analytics with the aim of optimizing processes, introducing preventive maintenance, and making supply chains transparent.

This study also captures sponsors' outlook for outsourcing by-products and by stage of drug lifecycle and the new engagement models being sought. In conjunction with the opportunities in product selection and manufacturing technologies, the study also has a detailed discussion on opportunities in the packaging segment in the light of new serialization requirements, track-and-trace solutions designed to reduce to counterfeit medicine, primary and secondary packaging to meet regional and local regulatory requirements, as well as opportunities to collaborate with CROs for new drug development.

The study also discusses the impact of ongoing consolidation, profiles of leading CMOs, key CMOs to watch for, and, most importantly, the interest of private equity firms in the segment.

Key Issues Addressed

What is the total market size and projected growth of the global pharmaceutical contract manufacturing market? Which are the largest growth segments to be pursued?
How are the various regions around the globe positioned to monetize the market opportunities? What are the key regional barriers to entry?
Which are the biggest opportunities for small- and mid-sized companies in the highly fragmented market? What are the key challenges in the near and mid-term?
How are business models evolving across the value chain and impacting the different stakeholders?
How are product offerings in this market likely to emerge? What is the rate of innovation adoption, and how is it solving the unmet needs of customers?
Which are the key game-changing companies in the segment and how are they riding the growth curve?

Key Topics Covered

1. Executive Dashboard

Purpose of this Study
5-step Process to Transformational Growth
Key Findings
Key Questions this Study will Answer
Market Engineering Measurements
Big Market Themes
Strategic Imperatives for Success and Growth
Key Trends Impacting the CMO Industry

2. Market Overview

Scope and Geographic Segmentation
Segmentation
Vendor Landscape
Key Market Drivers
Expanding Role of CMOs in the Pharma Value Chain
Capex Growth Trends
CMOs - An Answer to the Drug Shortage Epidemic
Key Market Restraints
Implications of Global Policy Changes
Global Outlook
Main Global Trends

3. Market Dynamics

Rejuvenated Pipelines Driving Growth
Declining but Continued Growth in the Generics Segment
Outsourcing Outlook by End User
Outsourcing by Stage of Development
New Technology Trends Revolutionizing Manufacturing
Growing Impetus in Continuous Manufacturing
3D Printing - Manufacturing the Drug Closer to the Patient
CMO Engagement Models
Evolving Business Model

4. Revenue Forecast

Methodology and Assumptions
Market Engineering Measurements
Revenue Forecast by Product Type
Revenue Forecast by Region

5. Revenue Forecast - API

API CMO Market - Revenue Forecast by Customer Base
API CMO Market - Revenue Forecast by Region
Revenue Forecast Discussion
API Landscape

6. Revenue Forecast - FDF

FDF CMO Market - Revenue Forecast by Formulation Type
FDF CMO Market - Revenue Forecast by Region
Revenue Forecast Discussion

7. Revenue Forecast - US

US API CMO Market - Revenue Forecast by Customer Base
US FDF CMO Market - Revenue Forecast by Formulation Type

8. Revenue Forecast - Germany

Germany API CMO Market - Revenue Forecast by Customer Base
Germany FDF CMO Market - Revenue Forecast by Formulation Type
Growth Driver - Clinical Trials

9. Revenue Forecast - UK

UK API CMO Market - Revenue Forecast by Customer Base
UK FDF CMO Market - Revenue Forecast by Formulation Type

10. Revenue Forecast - France

France API CMO Market - Revenue Forecast by Customer Base
France FDF CMO Market - Revenue Forecast by Formulation Type

11. Revenue Forecast - Italy

Italy API CMO Market - Revenue Forecast by Customer Base
Italy FDF CMO Market - Revenue Forecast by Formulation Type

12. Revenue Forecast - Spain

Spain API CMO Market - Revenue Forecast by Customer Base
Spain FDF CMO Market - Revenue Forecast by Formulation Type

13. Revenue Forecast - Scandinavia

Scandinavia API CMO Market - Revenue Forecast by Customer Base
Scandinavia FDF CMO Market - Revenue Forecast by Formulation Type

14. Revenue Forecast - Benelux

Benelux API CMO Market - Revenue Forecast by Customer Base
Benelux FDF CMO Market - Revenue Forecast by Formulation Type

15. Revenue Forecast - India

India API CMO Market - Revenue Forecast by Customer Base
India FDF CMO Market - Revenue Forecast by Formulation Type

16. Revenue Forecast - China

China API CMO Market - Revenue Forecast by Customer Base
China FDF CMO Market - Revenue Forecast by Formulation Type
Barriers to Serving Regulated Markets

17. Revenue Forecast - Japan

Japan API CMO Market - Revenue Forecast by Customer Base
Japan FDF CMO Market - Revenue Forecast by Formulation Type

18. Competitive Landscape

Competitive Environment
Market Share Analysis
Revenues of Key Companies
Manufacturing Footprint
Key Companies to Watch
Key Themes in the Collaboration/Expansion Landscape

19. Key Collaboration Agreements in the Contract Manufacturing Market

Expansion Assessment
Collaboration Assessment
Thermo Fisher and Patheon - Redefining One-stop-shop
Growing PE Interest - The Required Leverage for Scale-up

20. Growth Opportunities

Major Growth Opportunities
Growth Opportunity 1 - Controlled Substances
CMOs Positioned to Capitalize on Medical Marijuana Market
Growth Opportunity 2 - Scalable Smart Packaging
Addressable Market Opportunity - Smart Packaging
Illustrative Smart Packaging Solutions
Amplifying Smart Packaging Utility - Trek Therapeutics Uses Ambrosus' Blockchain Solution for Quality Control
Growth Opportunity 3 - Manufacturing FDF in MENA
MENA Regional Developments
Examples of Strategies at Work
Key Companies to Watch in the MENA Region
Growth Opportunity 4 - High Potency API
HPAPI Market Potential
Growth Opportunity 5 - Smart Manufacturing
Top Technologies to Watch For
Case Study of IIoT Implementation - Decisyon's Solution
Growth Opportunity Matrix

21. The Last Word - Strategic Considerations for Staying on the Growth Trajectory

Top 3 Predictions for the Market
Winning Strategies for CMOs

22. Appendix

Abbreviations
Appendix - Medical Cannabis
Appendix - Pharma and Biotech Market in MENA Region
Leading ICT Participants Active in Life Science
API CMO Evolution Path
FDF CMO Industry Evolution
Growth Denominators
Growth Opportunity - Alleviating Data Integrity Issues
Data Integrity Statistics

For more information about this report visit https://www.researchandmarkets.com/r/unf2la

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets